VERNON REID SUTTON

Allopathic & Osteopathic Physicians|Pediatrics HOUSTON, TX NPI 1104906445

General Payments — all program years on this page

$82,876.50

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $29,845.70 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
BioMarin Pharmaceutical Inc. $20,543.616
Amgen Inc. $8,427.0910
CHIESI USA, INC. $875.002

By program year

Program yearAmountRecords
2018 $19,109.4525
2019 $9,636.968
2020 $125.001
2021 $3,100.002
2022 $4,086.884
2023 $16,972.5122
2024 $29,845.7018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1116163738 Amgen Inc. $114.72 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116163746 Amgen Inc. $175.00 04/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116163752 Amgen Inc. $284.39 04/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116163758 Amgen Inc. $412.20 04/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116163766 Amgen Inc. $23.65 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116163772 Amgen Inc. $23.65 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116163778 Amgen Inc. $44.99 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116163785 Amgen Inc. $58.49 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116163792 Amgen Inc. $140.00 04/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116163799 Amgen Inc. $7,150.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1127057589 BioMarin Pharmaceutical Inc. $1,728.00 11/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1127058113 BioMarin Pharmaceutical Inc. $272.49 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127058135 BioMarin Pharmaceutical Inc. $561.34 10/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127058155 BioMarin Pharmaceutical Inc. $13,373.78 10/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127058983 BioMarin Pharmaceutical Inc. $2,304.00 09/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1127063044 BioMarin Pharmaceutical Inc. $2,304.00 11/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1151822128 Chiesi USA, Inc. $575.00 01/11/2024 Honoraria Undisputed 01/23/2026 View at CMS
1151822132 Chiesi USA, Inc. $300.00 12/09/2024 Honoraria Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.